Low-voltage-activated potassium channels underlie the regulation of intrinsic firing properties of rat vestibular ganglion cells.
Individual primary vestibular afferents exhibit spontaneous activity the regularity of which can vary from regular to irregular. Different aspects of vestibular responsiveness have been associated with this dimension of regularity of resting discharge. Isolated rat vestibular ganglion cells (VGCs) showed heterogeneous intrinsic firing properties during sustained membrane depolarization: some neurons exhibited a strong adaptation generating just a single or a few spikes (phasic type), whereas other neurons showed moderate adaptation or tonic firing (tonic type). Tonic discharging VGCs were rare at postnatal days 5-7 and increased up to approximately 60% of neurons during postnatal 2-3 wk. To explore the major factors responsible for the discharge regularity of primary vestibular afferents, we investigated the contribution of K+ channels to the firing properties of isolated rat VGCs. Phasic firing became tonic firing in the presence of 4-aminopyridine or alpha-dendrotoxin, indicating that Kv1 potassium channels control the firing pattern of the phasic VGCs. Tetraethylammonium decreased the number of spikes during step current stimuli in all types. Blockade of Ca2+-activated K+ channels decreased the number of spikes in tonic VGCs. Our results suggest that Kv1 channels are critical both in determining the pattern of spike discharge in rat vestibular ganglion neurons and in their proportional change during maturation.
Iwasaki
Shinichi
S
Department of Otolaryngology, Faculty of Medicine, University of Tokyo, School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. iwashin-tky@umin.ac.jp
Chihara
Yasuhiro
Y
Komuta
Yukari
Y
Ito
Ken
K
Sahara
Yoshinori
Y
D015761:4-Aminopyridine / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D003627:Data Interpretation, Statistical; D004546:Elapid Venoms / Q000494:pharmacology; D004594:Electrophysiology; D005724:Ganglia / Q000166:cytology / Q000502:physiology*; D008564:Membrane Potentials / Q000187:drug effects; D009474:Neurons / Q000502:physiology*; D009475:Neurons, Afferent / Q000502:physiology; D018408:Patch-Clamp Techniques; D026902:Potassium Channel Blockers / Q000494:pharmacology; D051381:Rats; D051637:Shaker Superfamily of Potassium Channels / Q000502:physiology*; D013757:Tetraethylammonium Compounds / Q000494:pharmacology; D014725:Vestibular Nerve / Q000166:cytology / Q000502:physiology*
D004546:Elapid Venoms; D026902:Potassium Channel Blockers; D051637:Shaker Superfamily of Potassium Channels; D013757:Tetraethylammonium Compounds; C020273:dendrotoxin; D015761:4-Aminopyridine